Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002567
What this trial is testing

High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission

Who this might be right for
Bone Marrow AblationLeukemia
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)UnknownNCT01534702
What this trial is testing

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Who this might be right for
Acute Myeloid Leukemia
Hannover Medical School 60
Not applicableStudy completedNCT00301288
What this trial is testing

A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).

Who this might be right for
Non-Hodgkins Lymphoma
Royal Marsden NHS Foundation Trust 152
Early research (Phase 1)Study completedNCT00003927
What this trial is testing

Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00186641
What this trial is testing

High Dose Chemotherapy and Autologous Transplant for Breast Cancer

Who this might be right for
Graft vs Host Disease
Stanford University 203
Large-scale testing (Phase 3)Ended earlyNCT00448266
What this trial is testing

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT01666782
What this trial is testing

Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy

Who this might be right for
CancerInfluenza Viral Infections
Saad Jamshed MD 105
Testing effectiveness (Phase 2)Temporarily pausedNCT03187210
What this trial is testing

Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas

Who this might be right for
Lymphoma
Insel Gruppe AG, University Hospital Bern 20
Not applicableStudy completedNCT05517213
What this trial is testing

High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Affiliated Hospital to Academy of Military Medical Sciences 62
Testing effectiveness (Phase 2)Ended earlyNCT01222143
What this trial is testing

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University Health Network, Toronto 12
Early research (Phase 1)Study completedNCT05465681
What this trial is testing

Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Who this might be right for
Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
Fujian Shengdi Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)UnknownNCT00438581
What this trial is testing

Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
McGill University 40
Large-scale testing (Phase 3)UnknownNCT00747877
What this trial is testing

High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Leeds Cancer Centre at St. James's University Hospital 460
Large-scale testing (Phase 3)Ended earlyNCT00002819
What this trial is testing

Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)UnknownNCT02771743
What this trial is testing

Response-based Treatment of High-risk Neuroblastoma

Who this might be right for
Newly Diagnosed High Risk Neuroblastoma
Samsung Medical Center 54
Large-scale testing (Phase 3)Study completedNCT00005589
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
EBMT Solid Tumors Working Party 460
Testing effectiveness (Phase 2)Study completedNCT00003631
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 118
Large-scale testing (Phase 3)Study completedNCT00002556
What this trial is testing

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 312
Testing effectiveness (Phase 2)WithdrawnNCT06337331
What this trial is testing

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Northside Hospital, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06262438
What this trial is testing

CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

Who this might be right for
Acute Myeloid Leukemia in Children
Princess Maxima Center for Pediatric Oncology 60
Next Page